Cuprina Holdings (Cayman) Limited (CUPR) is up 171.0% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely catalyst is a regulatory overhang being lifted after the company disclosed it regained compliance with Nasdaq’s $1.00 minimum bid requirement, which also cancelled a previously scheduled delisting hearing. In micro-cap names, that kind of “delisting risk removed” update can trigger sharp, momentum-driven buying and short-covering.
Details:
Sources:
U.S. SEC, GlobeNewswire, ChartExchange
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CUPR Hedge Fund Activity
We have seen 2 institutional investors add shares of $CUPR stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 37,281 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,912
- XTX TOPCO LTD added 35,457 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,378
- STONEX GROUP INC. removed 13,260 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,305
- UBS GROUP AG removed 11,624 shares (-97.0%) from their portfolio in Q1 2026, for an estimated $3,402
- TWO SIGMA SECURITIES, LLC removed 10,346 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,028
- PROSPECT FINANCIAL GROUP LLC removed 9,615 shares (-38.6%) from their portfolio in Q1 2026, for an estimated $2,814
- CLEAR STREET GROUP INC. removed 100 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $40
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.